Valuation : Ningbo Menovo Pharmaceutical Co., Ltd.

Market Cap 8.94B 1.33B 1.15B 1.08B 983M 1.85B 126B 1.86B 12.76B 4.97B 64.21B 4.99B 4.89B 213B P/E 2024
41x
P/E 2025 40.9x
Enterprise Value 9.52B 1.42B 1.22B 1.15B 1.05B 1.97B 134B 1.98B 13.59B 5.29B 68.41B 5.32B 5.2B 227B EV / Sales 2024
2.46x
EV / Sales 2025 3.21x
Free-Float
70.49%
Yield 2024
0.39%
Yield 2025 0.81%
1 day-0.57%
1 week-0.38%
Current month-0.57%
1 month+6.39%
3 months-18.32%
6 months+64.52%
Current year+91.37%
1 week 25.8
Extreme 25.8
27.9
1 month 24.2
Extreme 24.2
35
Current year 13.71
Extreme 13.714285
50.28
1 year 13.55
Extreme 13.549999
50.28
3 years 7.11
Extreme 7.114285
50.28
5 years 7.11
Extreme 7.114285
50.28
10 years 6.9
Extreme 6.902446
50.28
Manager TitleAgeSince
Chief Executive Officer 52 2004-02-18
Director of Finance/CFO 55 2021-05-11
Investor Relations Contact 39 -
Director TitleAgeSince
Chairman 52 2004-02-18
Chairman 37 2021-05-11
Director/Board Member 55 2021-05-11
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/22 Sell

Director

44,300 0.0210%
11/14/22 Sell 13,500 0.0064%
7/12/22 Buy

Chief Executive Officer

3,430,253 1.6290%
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%-0.38%+41.40%+121.27% 1.34B
+0.28%-5.97%+58.34%+108.22% 1,031B
+2.01%-0.71%+53.07%+68.99% 641B
+1.39%-2.18%+23.57%+75.43% 453B
-1.50%-7.04%+33.55%+33.94% 349B
+6.25%+2.04%+28.97%+46.57% 290B
-0.07%-4.12%+0.95%+11.79% 252B
+1.92%-0.93%+52.28%+70.67% 232B
+0.51%-4.52%-19.50%-54.83% 201B
+2.45%+0.77%+32.71%+95.59% 181B
Average +1.40%-2.57%+30.53%+57.76% 363.11B
Weighted average by Cap. +1.60%-3.40%+38.39%+66.42%

Financials

2024 2025
Net sales 1.37B 204M 176M 166M 151M 284M 19.38B 285M 1.96B 763M 9.86B 767M 750M 32.7B 1.5B 224M 193M 181M 165M 311M 21.22B 313M 2.15B 835M 10.8B 840M 821M 35.8B
Net income 66.81M 9.94M 8.57M 8.06M 7.35M 13.82M 943M 13.89M 95.34M 37.11M 480M 37.32M 36.51M 1.59B 102M 15.21M 13.12M 12.34M 11.24M 21.14M 1.44B 21.26M 146M 56.79M 734M 57.1M 55.87M 2.43B
Net Debt 602M 89.51M 77.21M 72.63M 66.17M 124M 8.5B 125M 859M 334M 4.32B 336M 329M 14.33B 584M 86.92M 74.98M 70.53M 64.26M 121M 8.25B 121M 834M 325M 4.2B 326M 319M 13.91B
Logo Ningbo Menovo Pharmaceutical Co., Ltd.
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations. The Company is mainly engaged in three businesses. The contract development and manufacturing organization (CDMO) business mainly provides pharmaceutical companies with CDMO services for the entire preparation industry chain. The specialty API business is mainly engaged in the production and sales of APIs. The preparation business is mainly engaged in the production and sales of preparations. The Company's main products include valsartan, losartan, perindopril, rosuvastatin calcium, atorvastatin calcium and pregabalin. The Company's products are mainly used in cardiovascular, central nervous, antiviral, hypoglycemic, gastrointestinal and other therapeutic areas. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
2,370
Date Price Change Volume
26-09-01 CN¥26.30 -0.57% 26,419,171
26-08-31 CN¥26.45 -3.11% 40,230,373
26-08-28 CN¥27.30 +0.74% 46,211,610
26-08-27 CN¥27.10 +3.59% 57,158,138
26-08-26 CN¥26.16 -2.97% 42,098,193

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603538 Stock